MPW - Medical Properties Trust, Inc.
NYSE
->
Real Estate
->
REIT—Healthcare Facilities
Birmingham,
United States
Type: Equity
MPW price evolution
MPW
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $606.55 | $224.34 | $250.02 | |
| Short term investments | ||||
| Net receivables | $685.74 | $703.74 | $712.06 | $635.99 |
| Inventory | ||||
| Total current assets | $961.36 | $1270.82 | $901.91 | $886 |
| Long term investments | ||||
| Property, plant & equipment | $11798.47 | $12112.58 | $13239.25 | $16623.26 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | $2284.38 | $2671.59 | $3545.71 | |
| Total assets | $15236.16 | $16194.74 | $17300.96 | $18304.84 |
| Current liabilities | ||||
| Accounts payable | $418.34 | $446.89 | $302.53 | $412.18 |
| Deferred revenue | $25.7 | $32.08 | $37.96 | |
| Short long term debt | ||||
| Total current liabilities | $554.97 | $606.9 | $465.79 | $568.78 |
| Long term debt | $9215.75 | $9369.06 | $10098.72 | $10064.24 |
| Total noncurrent liabilities | ||||
| Total debt | $9529.07 | $10261.99 | $10220.84 | |
| Total liabilities | $9797.59 | $10001.67 | $10596.59 | $10673.24 |
| Shareholders' equity | ||||
| Retained earnings | -$3197.51 | -$2348.17 | -$1846.86 | -$971.81 |
| Other shareholder equity | $57.11 | -$33.91 | -$18.84 | $42.5 |
| Total shareholder equity | $6190.18 | $6702.1 | $7631.6 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $250.02 | $235.67 | $459.23 | $549.88 |
| Short term investments | ||||
| Net receivables | $635.99 | $787.17 | $784.75 | $536.67 |
| Inventory | ||||
| Total current assets | $886 | $1022.83 | $1187.75 | $4035.56 |
| Long term investments | $1123.62 | |||
| Property, plant & equipment | $16623.26 | $17667.3 | $16432.67 | $13504.4 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | $3545.71 | $3170.61 | $2509.68 | $1981.99 |
| Total assets | $18304.84 | $19658 | $20519.8 | $16829.01 |
| Current liabilities | ||||
| Accounts payable | $412.18 | $621.32 | $607.79 | $438.75 |
| Deferred revenue | $37.96 | $27.73 | $25.56 | $36.18 |
| Short long term debt | ||||
| Total current liabilities | $568.78 | $767.45 | $763.86 | $446.06 |
| Long term debt | $10064.24 | $10268.41 | $11284.71 | $8865.46 |
| Total noncurrent liabilities | ||||
| Total debt | $10220.84 | $10414.54 | $11440.77 | $9010.23 |
| Total liabilities | $10673.24 | $11065.16 | $12074.13 | $9485.16 |
| Shareholders' equity | ||||
| Retained earnings | -$971.81 | $116.28 | -$87.69 | -$71.41 |
| Other shareholder equity | $42.5 | -$59.18 | -$36.73 | -$51.32 |
| Total shareholder equity | $7631.6 | $8592.84 | $8440.19 | $7338.53 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $266.56 | $271.32 | -$122.38 | |
| Cost of revenue | $109.9 | $80.4 | ||
| Gross Profit | $156.66 | $190.91 | -$125.68 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $35.33 | $33.35 | ||
| Total operating expenses | $35.33 | $33.35 | $107.44 | |
| Operating income | $121.33 | $157.56 | ||
| Income from continuing operations | ||||
| EBIT | -$204.65 | -$755.99 | ||
| Income tax expense | $14.56 | $10.95 | $3.98 | |
| Interest expense | $101.43 | $108.69 | -$123.21 | |
| Net income | ||||
| Net income | -$320.63 | -$875.63 | -$664.29 | |
| Income (for common shares) | -$320.63 | -$875.63 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $871.8 | $1542.85 | $1249.24 | |
| Cost of revenue | $378.67 | $289.13 | ||
| Gross Profit | $830.23 | $1164.18 | $960.1 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $160.49 | $131.66 | ||
| Total operating expenses | $748.95 | $160.49 | $131.66 | |
| Operating income | $1003.68 | $828.44 | ||
| Income from continuing operations | ||||
| EBIT | $1317.53 | $791.23 | ||
| Income tax expense | -$130.68 | $55.9 | $31.06 | |
| Interest expense | -$397.2 | $359.04 | $328.73 | |
| Net income | ||||
| Net income | -$558.12 | $902.6 | $431.45 | |
| Income (for common shares) | $902.6 | $431.45 | ||
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$320.63 | -$875.63 | -$663.94 | |
| Operating activities | ||||
| Depreciation | $103.86 | $77.21 | $79.93 | |
| Business acquisitions & disposals | -$105.62 | |||
| Stock-based compensation | $8.52 | $7.63 | $3.53 | |
| Total cash flows from operations | $35.26 | $74.34 | $135.42 | |
| Investing activities | ||||
| Capital expenditures | $1488.73 | -$110.33 | $198.14 | |
| Investments | -$181 | -$8.93 | -$27.92 | |
| Total cash flows from investing | $1226.6 | $1202.12 | -$119.26 | $170.22 |
| Financing activities | ||||
| Dividends paid | -$272.91 | -$89.81 | -$92.76 | -$91.23 |
| Sale and purchase of stock | ||||
| Net borrowings | -$763.43 | $108.89 | -$311.89 | |
| Total cash flows from financing | -$1379.57 | -$853.52 | $22.07 | -$402.73 |
| Effect of exchange rate | $7.97 | -$2.91 | -$2.89 | $7.16 |
| Change in cash and equivalents | $23.8 | $383.86 | -$22.84 | -$97.09 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$556.48 | $902.6 | $656.02 | $431.45 |
| Operating activities | ||||
| Depreciation | $616.13 | $345.58 | $333.78 | $275.95 |
| Business acquisitions & disposals | -$235.19 | -$1332.96 | -$5350.24 | -$4249.18 |
| Stock-based compensation | $33.25 | $49.42 | $52.11 | $47.15 |
| Total cash flows from operations | $505.79 | $739.01 | $811.66 | $617.64 |
| Investing activities | ||||
| Capital expenditures | $488.91 | $1868.94 | -$110.5 | -$10.35 |
| Investments | $263.84 | -$139.93 | $1602.32 | $1312.76 |
| Total cash flows from investing | $517.56 | $396.06 | -$3858.41 | -$2946.77 |
| Financing activities | ||||
| Dividends paid | -$615.39 | -$698.53 | -$643.47 | -$567.97 |
| Sale and purchase of stock | -$17.94 | $1051.23 | $411.1 | |
| Net borrowings | -$407 | -$591.11 | $2522.04 | $1536.24 |
| Total cash flows from financing | -$1020.33 | -$1342.52 | $2947.61 | $1401.07 |
| Effect of exchange rate | $11.4 | -$12.89 | $4.66 | $16.44 |
| Change in cash and equivalents | $3.02 | -$207.46 | -$99.15 | -$928.06 |
News
Fundamentals
| Market cap | $3.06B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 600.23M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.40 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.73 |
| Quick ratio | N/A |